<DOC>
	<DOCNO>NCT01880424</DOCNO>
	<brief_summary>This clinical trial international , multicenter , randomize , double-blind , placebo-controlled , parallel-group trial compare one dose linaclotide placebo . Approximately 800 patient diagnosis IBS-C ( modify Rome III criterion ) randomize 60 trial center China , Australia , New Zealand . The trial consist 21 day screen , 14 21 day pre-treatment , 12 week double-blind treatment , 2 week follow-up . At end Pre-treatment Period , patient meet entry criterion trial randomize one two double-blind treatment group : 290 ug linaclotide , placebo ( 1:1 ) .</brief_summary>
	<brief_title>A Phase 3 , International , Multicenter , Randomized , Double-blind , Placebo-controlled , Parallel-group Efficacy Safety Trial Linaclotide Administered Orally 12 Weeks Patients With Irritable Bowel Syndrome With Constipation ( IBS-C )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>1 . Patient sign Informed Consent Form ( ICF ) . 2 . Patient Must pregnant breastfeed agree use birth control 3 . Patient meet colonoscopy requirement define American Gastroenterological Association guideline clinicallysignificant laboratory physical examination finding ; 4 . Patient meet protocoldefined criterion Irritable Bowel Syndrome Constipation ( IBSC ) , include stool frequency , strain , stool consistency , abdominal pain , abdominal discomfort criterion 5 . Patient meet protocoldefined eDiary completion Compliance agree refrain make new , major lifestyle change may affect IBSC symptom 1 . Recent history mushy watery stool 2 . Various medical condition , medical history , family medical history would make patient good candidate study 3 . Patient currently unexplained clinically significant alarm symptom systemic sign infection colitis . 4 . Surgery gastrointestinal tract 5 . Usage prohibit medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>